Research to Prevent Blindness Archives
Inflammation implicated in exfoliation syndrome
Mar. 28, 2023—Computational genetics tools have implicated inflammatory pathways in exfoliation syndrome, the most common cause of secondary glaucoma, which can result in blindness.
Opening a window to glaucoma
Oct. 10, 2022—A metalloprotease enzyme plays an important role in retinal ganglion cell development, Vanderbilt researchers discovered; studying it and other family members may lead to the identification of novel targets for treating glaucoma.
Calkins lands national award for research on blinding eye diseases
Sep. 8, 2022—Vanderbilt's David Calkins, PhD, has been selected by the Research to Prevent Blindness and Association of University Professors of Ophthalmology to receive the 2023 David F. Weeks Award for Outstanding Vision Research.
Mitochondria and retinal degeneration
Aug. 15, 2022—Vanderbilt researchers have developed a new cellular model for exploring mitochondrial dysfunction in age-related macular degeneration, the leading cause of blindness in people over 65.
RPB grant to support research, treatment of blinding diseases
Jul. 9, 2020—Research to Prevent Blindness (RPB) recently awarded a grant to investigators in Vanderbilt’s Department of Ophthalmology and Visual Sciences to support research into the causes, treatment and prevention of blinding diseases.
Insights on diabetic retinopathy
Jan. 23, 2020—A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report.
Potassium balance and glaucoma
Jul. 15, 2019—Vanderbilt Eye Institute researchers have discovered that an imbalance in the ionic environment of retinal ganglion cells may contribute to functional impairments in glaucoma.
Research to Prevent Blindness awards grants to Department of Ophthalmology
Jul. 1, 2019—Vanderbilt Eye Institute receives grants to Research to study causes, treatment and prevention of blinding diseases.
Novel methods to treat glaucoma
Nov. 8, 2018—Increasing a certain signaling molecule prevents the degeneration of retinal cells that are lost in glaucoma, suggesting a new way to treat this disease.
Calkins lands innovation award from Research to Prevent Blindness
Jun. 28, 2018—Jun. 28, 2018—David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has been granted one of the preeminent awards in vision research — the Research to Prevent Blindness (RPB) Stein Innovation Award.
Two receive Research to Prevent Blindness grants
Jul. 21, 2016—Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology.
VEI receives grant from Research to Prevent Blindness for research and education
Jun. 25, 2015—The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000.
